wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36821702-D2851C60-8377-42D7-881F-5AE7641C8904
Q36821702-D2851C60-8377-42D7-881F-5AE7641C8904
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36821702-D2851C60-8377-42D7-881F-5AE7641C8904
A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancer.
P2860
Q36821702-D2851C60-8377-42D7-881F-5AE7641C8904
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36821702-D2851C60-8377-42D7-881F-5AE7641C8904
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d8e339365937b85e4e31da53200342448517285c
P2860
Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2 overexpressing breast cancer: a phase I dose-escalation study.